blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1290182

EP1290182 - SPHINGOSINE KINASE AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.10.2011
Database last updated on 12.10.2024
Most recent event   Tooltip27.09.2013Lapse of the patent in a contracting state
New state(s): TR
published on 30.10.2013  [2013/44]
Applicant(s)For all designated states
MEDVET SCIENCE PTY. LTD.
20 Dalgleish Street
Thebarton, S.A. 5031 / AU
[2003/49]
Former [2003/11]For all designated states
Medvet Science Pty. Ltd.
Level 3, Hanson Centre, IMVS, Frome Road
Adelaide, S.A. 5000 / AU
Inventor(s)01 / VADAS, Mathew
8 Branch Road
Stirling, S.A. 5152 / AU
02 / GAMBLE, Jennifer
8 Branch Road
Stirling, S.A. 5152 / AU
03 / XIA, Pu
97 Shakespeare Avenue
Magill, S.A. 5072 / AU
04 / WANG, Lijun
97 Shakespeare Avenue
Magill, S.A. 5072 / AU
 [2003/11]
Representative(s)Leathley, Anna Elisabeth, et al
Dehns St Bride's House 10 Salisbury Square London
EC4Y 8JD / GB
[N/P]
Former [2009/39]Leathley, Anna Elisabeth, et al
Frank B. Dehn & Co. St Bride's House 10 Salisbury Square London
EC4Y 8JD / GB
Former [2003/11]Jones, Elizabeth Louise, et al
Frank B. Dehn & Co., 179 Queen Victoria Street
London EC4V 4EL / GB
Application number, filing date01929118.611.05.2001
[2003/11]
WO2001AU00539
Priority number, dateAU2000PQ0744711.05.2000         Original published format: AU PQ744700
[2003/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0185953
Date:15.11.2001
Language:EN
[2001/46]
Type: A1 Application with search report 
No.:EP1290182
Date:12.03.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 15.11.2001 takes the place of the publication of the European patent application.
[2003/11]
Type: B1 Patent specification 
No.:EP1290182
Date:22.12.2010
Language:EN
[2010/51]
Search report(s)International search report - published on:AU15.11.2001
(Supplementary) European search report - dispatched on:EP24.11.2005
ClassificationIPC:A61K31/133, A61P35/00
[2010/24]
CPC:
C12N9/1205 (EP,US); A61K31/13 (EP,US); A61P35/00 (EP);
A61P43/00 (EP); A61K38/00 (EP,US)
Former IPC [2010/22]C12N15/54, A61K31/13, A61K35/14, A61K31/133
Former IPC [2003/11]C12N15/54, A61K31/13, A61K35/14, A61K38/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/11]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:SPHINGOSINKINASE UND DEREN VERWENDUNGEN[2010/24]
English:SPHINGOSINE KINASE AND USES THEREOF[2003/11]
French:SPHINGOSINE KINASE ET SES UTILISATIONS[2003/11]
Former [2003/11]SPHINGOSINEKINASE UND DEREN VERWENDUNGEN
Entry into regional phase11.12.2002National basic fee paid 
11.12.2002Search fee paid 
11.12.2002Designation fee(s) paid 
11.12.2002Examination fee paid 
Examination procedure09.11.2001Request for preliminary examination filed
International Preliminary Examining Authority: AU
11.12.2002Examination requested  [2003/11]
28.02.2003Amendment by applicant (claims and/or description)
10.03.2006Despatch of a communication from the examining division (Time limit: M08)
06.03.2007Reply to a communication from the examining division
26.06.2007Despatch of a communication from the examining division (Time limit: M06)
18.04.2008Reply to a communication from the examining division
01.08.2008Despatch of a communication from the examining division (Time limit: M08)
15.05.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
27.07.2009Reply to a communication from the examining division
20.04.2010Cancellation of oral proceeding that was planned for 22.04.2010
22.04.2010Date of oral proceedings (cancelled)
23.04.2010Despatch of a communication from the examining division (Time limit: M02)
24.04.2010Reply to a communication from the examining division
01.07.2010Communication of intention to grant the patent
05.11.2010Fee for grant paid
05.11.2010Fee for publishing/printing paid
Opposition(s)23.09.2011No opposition filed within time limit [2011/48]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
18.04.2008Request for further processing filed
18.04.2008Full payment received (date of receipt of payment)
Request granted
05.05.2008Decision despatched
06.03.2007Request for further processing filed
06.03.2007Full payment received (date of receipt of payment)
Request granted
20.03.2007Decision despatched
Fees paidRenewal fee
11.12.2002Renewal fee patent year 03
14.09.2004Renewal fee patent year 04
26.08.2005Renewal fee patent year 05
23.03.2006Renewal fee patent year 06
14.05.2007Renewal fee patent year 07
28.03.2008Renewal fee patent year 08
12.05.2009Renewal fee patent year 09
26.05.2010Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.05.200404   M06   Fee paid on   14.09.2004
31.05.200505   M06   Fee paid on   26.08.2005
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.12.2010
BE22.12.2010
CY22.12.2010
DK22.12.2010
FI22.12.2010
IT22.12.2010
NL22.12.2010
SE22.12.2010
TR22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
IE11.05.2011
LU11.05.2011
CH31.05.2011
LI31.05.2011
MC31.05.2011
[2013/44]
Former [2013/25]AT22.12.2010
BE22.12.2010
CY22.12.2010
DK22.12.2010
FI22.12.2010
IT22.12.2010
NL22.12.2010
SE22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
IE11.05.2011
LU11.05.2011
CH31.05.2011
LI31.05.2011
MC31.05.2011
Former [2012/20]AT22.12.2010
BE22.12.2010
CY22.12.2010
DK22.12.2010
FI22.12.2010
IT22.12.2010
NL22.12.2010
SE22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
IE11.05.2011
CH31.05.2011
LI31.05.2011
MC31.05.2011
Former [2012/07]AT22.12.2010
BE22.12.2010
CY22.12.2010
DK22.12.2010
FI22.12.2010
IT22.12.2010
NL22.12.2010
SE22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
CH31.05.2011
LI31.05.2011
MC31.05.2011
Former [2012/05]AT22.12.2010
BE22.12.2010
CY22.12.2010
DK22.12.2010
FI22.12.2010
IT22.12.2010
NL22.12.2010
SE22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
MC31.05.2011
Former [2012/03]AT22.12.2010
BE22.12.2010
CY22.12.2010
DK22.12.2010
FI22.12.2010
IT22.12.2010
NL22.12.2010
SE22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
Former [2011/47]AT22.12.2010
BE22.12.2010
CY22.12.2010
DK22.12.2010
FI22.12.2010
NL22.12.2010
SE22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
Former [2011/42]AT22.12.2010
BE22.12.2010
CY22.12.2010
FI22.12.2010
NL22.12.2010
SE22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
Former [2011/35]AT22.12.2010
BE22.12.2010
CY22.12.2010
FI22.12.2010
SE22.12.2010
GR23.03.2011
ES02.04.2011
PT22.04.2011
Former [2011/31]AT22.12.2010
CY22.12.2010
FI22.12.2010
SE22.12.2010
Former [2011/24]CY22.12.2010
FI22.12.2010
SE22.12.2010
Documents cited:Search[X]JPH10182627  ;
 [E]WO0174837  (SANKYO CO [JP], et al) [E] 1-27 * page 7 * * page 8, paragraph 3 - paragraph 5 * * page 25, paragraph 2 - paragraph 5 *;
 [X]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 1998, no. 37, Database accession no. 1998-433849, XP002353566 & JPH10182627 A 19980707 (SANKYO CO LTD) [X] 1-27 * abstract *
 [PX]  - XIA P ET AL., "An oncogenic role of shingosine kinase", CURRENT BIOLOGY, (20001117), vol. 10, no. 23, pages 1527 - 1530, XP002350767 [PX] 1-27 * page 1527, column L * * page 1530, column L *

DOI:   http://dx.doi.org/10.1016/S0960-9822(00)00834-4
International search[X]WO9912533  (MEDVET SCIENCE PTY LTD [AU], et al);
 [X]WO9961581  (DEAN OF RESEARCH AND GRADUATE [US], et al);
 [X]WO0000207  (LOS ANGELES CHILDRENS HOSPITAL [US], et al);
 [XP]WO0070028  (JOHNSON & JOHNSON RES PTY LTD [AU], et al);
 [XP]WO0131029  (WARNER LAMBERT CO [US], et al);
 [X]  - XIA ET AL., "High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway", JOURNAL OF BIOLOGICAL CHEMISTRY, (1999), vol. 274, pages 33143 - 33147, XP002962413

DOI:   http://dx.doi.org/10.1074/jbc.274.46.33143
 [X]  - NIWA ET AL., "Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the FMLP-stimulated superoxide production", LIFE SCIENCES, (200003), vol. 66, pages 245 - 256, XP002962410

DOI:   http://dx.doi.org/10.1016/S0024-3205(99)00587-1
 [X]  - HAUSER ET AL., "Role of ceramide in mitogenesis induced by exogenous sphingoid bases", JOURNAL OF BIOLOGICAL CHEMISTRY, (1994), vol. 269, pages 6803 - 6809, XP002962412
 [X]  - NAKAMURA ET AL., "Survival by Mac-1 mediated adherence and anoikis in phorbol ester-treated HL-60 cells", JOURNAL OF BIOLOGICAL CHEMISTRY, (1998), vol. 273, pages 15345 - 15351, XP002962409

DOI:   http://dx.doi.org/10.1074/jbc.273.25.15345
 [X]  - XIA ET AL., "Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway", PROC. NATL. ACAD. SCI. USA, (1998), vol. 95, pages 14196 - 14201, XP002962411

DOI:   http://dx.doi.org/10.1073/pnas.95.24.14196
 [X]  - XIA ET AL., "Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells", JOURNAL OF BIOLOGICAL CHEMISTRY, (1999), vol. 274, pages 34499 - 34505, XP002962408

DOI:   http://dx.doi.org/10.1074/jbc.274.48.34499
 [XP]  - PYNE ET AL., "Sphingosine 1-phosphate signalling in mammalian cells", BIOCHEM. J., (200009), vol. 349, pages 385 - 402, XP000939036

DOI:   http://dx.doi.org/10.1042/0264-6021:3490385
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.